Jefferies puts Kendle at buy

Kendle International was rated at buy by Jefferies & Co., Inc. analyst David Windley on the company's strong quarterly results. The company reported first-quarter earnings per share of $0.33 compared with Jefferies' estimate of $0.30. Revenue increased $7 million to $59.8 million. Shares of the Cincinnati clinical research organization were up $1.12, or 3.07%, at $37.55 on volume of 292,828 shares versus the three-month running average of 167,524 shares. (Nasdaq: KNDL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.